Luxist Web Search

  1. Ad

    related to: novartis bayer news release

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis to buy radiology drug specialist Mariana for $1 billion

    www.aol.com/news/novartis-buy-radiology-drug...

    Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug ...

  3. Imatinib - Wikipedia

    en.wikipedia.org/wiki/Imatinib

    Imatinib is a 2- phenyl amino pyrimidine derivative that functions as a specific inhibitor of a number of tyrosine kinase enzymes. It occupies the TK active site, leading to a decrease in activity. There are a large number of TK enzymes in the body, including the insulin receptor.

  4. Novartis signs gene therapy deal with Voyager for $100 ... - AOL

    www.aol.com/news/novartis-signs-gene-therapy...

    (Reuters) -Voyager Therapeutics said on Tuesday Swiss-based drugmaker Novartis would pay $100 million upfront as part of a licensing deal to develop gene therapy candidates for genetic disorders.

  5. Novartis begins tender offer for cancer-focused MorphoSys - AOL

    www.aol.com/news/novartis-begins-tender-offer...

    BERLIN (Reuters) -Novartis said on Thursday it has launched a tender offer to acquire MorphoSys, a German developer of cancer treatments, for an aggregate 2.7 billion euros ($2.9 billion). Reuters ...

  6. Daniel Vasella - Wikipedia

    en.wikipedia.org/wiki/Daniel_Vasella

    Businessman. Spouse. Anne-Laurence. Children. 3. Daniel Lucius Vasella (born 15 August 1953) is a Swiss medical doctor, author, and executive who was CEO and chairman of the Swiss pharmaceutical company Novartis AG, the world's fifth largest drug company. [1] [2] During his tenure Novartis shares fell 10%, compared to the industry average.

  7. Ofatumumab - Wikipedia

    en.wikipedia.org/wiki/Ofatumumab

    Ofatumumab is a fully human monoclonal antibody to CD20, which appears to provide rapid B-cell depletion. [13] Under the brand name Kesimpta, it is approved for the treatment of multiple sclerosis in the United States as well as in the European Union and other regions. [9] [11] Under the brand name Arzerra, it is approved for the treatment of ...

  8. Bayer woes pile up as blood thinner drug trial fails - AOL

    www.aol.com/news/bayer-cancels-asundexian-phase...

    Its shares slid 16.4% at 0903 GMT on Monday to their lowest in 12 years, with separate news overnight the company had been ordered to pay $1.56 billion in the latest U.S. lawsuit over its commonly ...

  9. Sandoz - Wikipedia

    en.wikipedia.org/wiki/Sandoz

    Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until ...

  1. Ad

    related to: novartis bayer news release